Akira Yamamoto, MD
Orthopedic Surgery · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 7
Offices
7 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 057007 · 058496 · 059720 · 059765 · 757662 · El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yamamoto’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A103526 · Current
Licensed to practise in California · since 2008 · expires 2027-11-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$333,402
Medicare paid this office $333,402 for 589 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 76 | $95,218 | $1,161 |
| Return visit (30+ min) | 477 | $67,794 | $113 |
| Replacement of thigh bone and hip joint with prosthesis | 51 | $62,975 | $1,211 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 27 | $15,187 | None |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 69 | $13,254 | $184 |
See all 12 services
| Replacement of knee joint, both sides of knee | 76 | $95,218 | $1,161 |
| Return visit (30+ min) | 477 | $67,794 | $113 |
| Replacement of thigh bone and hip joint with prosthesis | 51 | $62,975 | $1,211 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 27 | $15,187 | None |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 69 | $13,254 | $184 |
| Aspiration and/or injection of fluid from large joint | 64 | $8,190 | $69 |
| New patient visit (45+ min) | 40 | $5,978 | $149 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 40 | $3,371 | $84 |
| Short return visit (20+ min) | 42 | $3,003 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,326 | $155 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 101 | $1,547 | $15 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 40 | $220 | None |
Procedures Medicare counted
| Hip replacement | 60 | More than 91% of doctors who do this |
| Knee replacement | 108 | More than 94% of doctors who do this |
Who their Medicare patients are
589 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 11% · Women 68% · Also on Medicaid 10% · Health risk score 0.89. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 63% · Diabetes 21% · Coronary heart disease 20% · Chronic kidney disease 15% · Cancer 15% · Depression 15% · Atrial fibrillation 14% · Heart failure 9% · COPD 7% · Dementia 6% · Stroke 5%.
The office billed $1,655,410, Medicare allowed $431,016 and paid $333,402; for 3,821 services of 47 kinds; $16,849 of it was for drugs given in the office and $316,553 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 589 | 3,821 | 76 | 0.89 | $1,655,410 | $333,402 |
| 2023 | 513 | 3,246 | 76 | 0.94 | $1,350,454 | $292,931 |
| 2022 | 489 | 3,907 | 77 | 0.97 | $1,321,864 | $294,463 |
| 2021 | 579 | 4,551 | 77 | 0.98 | $1,330,642 | $316,771 |
| 2020 | 421 | 2,250 | 75 | 1.04 | $1,040,061 | $229,769 |
| 2019 | 563 | 2,621 | 76 | 1.04 | $1,255,291 | $271,050 |
| 2018 | 598 | 2,725 | 76 | 1.13 | $1,148,813 | $264,835 |
| 2017 | 591 | 3,652 | 75 | 1.08 | $1,076,475 | $256,630 |
| 2016 | 588 | 3,497 | 76 | 1.09 | $986,492 | $240,675 |
| 2015 | 482 | 1,982 | 76 | 1.17 | $818,710 | $206,775 |
| 2014 | 500 | 1,588 | 77 | 1.10 | $717,228 | $172,277 |
| 2013 | 362 | 1,435 | 76 | 1.10 | $515,174 | $129,986 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Replacement of knee joint, both sides of knee | 68 | $83,229 | $1,189 |
| Return visit (30+ min) | 312 | $49,939 | $115 |
| Replacement of thigh bone and hip joint with prosthesis | 34 | $41,955 | $1,199 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 67 | $12,918 | $187 |
| Short return visit (20+ min) | 124 | $11,767 | $78 |
| New patient visit (45+ min) | 80 | $10,905 | $136 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 20 | $10,605 | None |
| Aspiration and/or injection of fluid from large joint | 75 | $8,786 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,359 | $160 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 34 | $3,066 | $88 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | $221 | None |
2022: 13 services
| Replacement of knee joint, both sides of knee | 65 | $81,225 | $1,194 |
| Replacement of thigh bone and hip joint with prosthesis | 34 | $41,715 | $1,192 |
| Return visit (30+ min) | 252 | $33,893 | $109 |
| Short return visit (20+ min) | 185 | $18,346 | $83 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 25 | $13,537 | None |
| New patient visit (45+ min) | 96 | $13,270 | $138 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 65 | $12,871 | $189 |
| Aspiration and/or injection of fluid from large joint | 73 | $10,484 | $68 |
| Removal of deep implant from bone | 11 | $4,237 | $385 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,456 | $182 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 34 | $3,056 | $87 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 13 | $2,969 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $225 | None |
2021: 15 services
| Replacement of thigh bone and hip joint with prosthesis | 42 | $50,429 | $1,201 |
| Replacement of knee joint, both sides of knee | 39 | $48,325 | $1,208 |
| Return visit (30+ min) | 270 | $37,061 | $116 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 43 | $23,918 | None |
| Long return visit (40+ min) | 123 | $21,239 | $167 |
| Aspiration and/or injection of fluid from large joint | 124 | $14,624 | $67 |
| Short return visit (20+ min) | 146 | $13,092 | $77 |
| New patient visit (60+ min) | 67 | $12,520 | $187 |
| New patient visit (45+ min) | 56 | $7,865 | $140 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 40 | $7,618 | $190 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $3,598 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,322 | $185 |
| Computer-assisted, fluoroscopic image-guided musculoskeletal surgical navigational orthopedic operation | 35 | $3,085 | $88 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $890 | $68 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 73 | $384 | None |
2020: 10 services
| Replacement of knee joint, both sides of knee | 45 | $60,817 | $1,267 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $36,564 | $1,261 |
| Short return visit (20+ min) | 224 | $20,533 | $66 |
| Return visit (30+ min) | 126 | $12,434 | $90 |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 14 | $8,656 | None |
| Aspiration and/or injection of fluid from large joint | 62 | $7,603 | $68 |
| New patient visit (45+ min) | 53 | $7,288 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,009 | $182 |
| New patient visit (30+ min) | 27 | $2,681 | $99 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $232 | None |
2019: 11 services
| Replacement of knee joint, both sides of knee | 39 | $50,966 | $1,213 |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $27,497 | $1,250 |
| Short return visit (20+ min) | 271 | $23,699 | $63 |
| Return visit (30+ min) | 180 | $17,874 | $89 |
| Aspiration and/or injection of fluid from large joint | 141 | $15,016 | $57 |
| New patient visit (45+ min) | 106 | $13,245 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,329 | $181 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 29 | $6,892 | None |
| Computer-assisted surgery for muscle and bone procedure | 28 | $3,964 | $132 |
| New patient visit (30+ min) | 19 | $1,600 | $84 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 105 | $304 | None |
2018: 13 services
| Replacement of thigh bone and hip joint with prosthesis | 32 | $40,333 | $1,222 |
| Replacement of knee joint, both sides of knee | 23 | $27,779 | $1,208 |
| Aspiration and/or injection of fluid from large joint | 194 | $23,885 | $59 |
| Short return visit (20+ min) | 280 | $23,294 | $62 |
| Return visit (30+ min) | 184 | $18,385 | $93 |
| New patient visit (45+ min) | 118 | $16,584 | $141 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 27 | $10,508 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $8,043 | $179 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 14 | $6,835 | None |
| Injection of contrast for imaging of hip under anesthesia | 11 | $3,007 | $251 |
| New patient visit (30+ min) | 28 | $2,790 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 159 | $819 | None |
| Short return visit | 12 | $469 | $39 |
2017: 13 services
| Replacement of knee joint, both sides of knee | 26 | $33,050 | $1,224 |
| Replacement of thigh bone and hip joint with prosthesis | 22 | $26,922 | $1,224 |
| Short return visit (20+ min) | 271 | $24,676 | $63 |
| New patient visit (45+ min) | 164 | $23,109 | $141 |
| Return visit (30+ min) | 213 | $21,591 | $93 |
| Aspiration and/or injection of fluid from large joint | 179 | $21,227 | $60 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 25 | $14,275 | None |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 18 | $13,504 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,983 | $181 |
| Long return visit (40+ min) | 13 | $1,605 | $123 |
| New patient visit (30+ min) | 18 | $1,538 | $85 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 135 | $982 | None |
| Short return visit | 14 | $548 | $37 |
2016: 12 services
| Replacement of thigh bone and hip joint with prosthesis | 20 | $25,665 | $1,222 |
| Return visit (30+ min) | 249 | $23,735 | $89 |
| Aspiration and/or injection of fluid from large joint | 191 | $23,556 | $61 |
| Short return visit (20+ min) | 259 | $23,038 | $61 |
| Replacement of knee joint, both sides of knee | 17 | $21,862 | $1,215 |
| New patient visit (45+ min) | 120 | $16,398 | $137 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 26 | $14,625 | None |
| Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 15 | $11,035 | None |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 24 | $8,870 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,080 | $177 |
| New patient visit (30+ min) | 43 | $3,728 | $87 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 144 | $1,043 | None |
2015: 11 services
| Return visit (30+ min) | 260 | $31,717 | $95 |
| Replacement of knee joint, both sides of knee | 22 | $29,502 | $1,283 |
| New patient visit (45+ min) | 123 | $18,356 | $149 |
| Short return visit (20+ min) | 177 | $18,010 | $68 |
| Replacement of thigh bone and hip joint with prosthesis | 11 | $14,077 | $1,280 |
| Treatment of broken neck of thigh bone with plate/screw implant | 11 | $12,520 | $1,138 |
| Aspiration and/or injection of fluid from large joint | 116 | $12,077 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,207 | $188 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $3,215 | None |
| New patient visit (30+ min) | 21 | $1,898 | $90 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 98 | $675 | None |
2014: 10 services
| Return visit (30+ min) | 243 | $25,223 | $89 |
| Replacement of knee joint, both sides of knee | 19 | $24,282 | $1,214 |
| Short return visit (20+ min) | 161 | $15,113 | $64 |
| New patient visit (45+ min) | 101 | $14,084 | $139 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $11,551 | $1,050 |
| Aspiration and/or injection of fluid from large joint | 110 | $10,032 | $56 |
| New patient visit (30+ min) | 73 | $6,475 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,336 | $171 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 22 | $4,613 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 93 | $701 | None |
2013: 8 services
| Short return visit (20+ min) | 152 | $19,684 | $66 |
| Return visit (30+ min) | 124 | $14,447 | $97 |
| Aspiration and/or injection of fluid from large joint | 89 | $11,755 | $54 |
| New patient visit (45+ min) | 79 | $11,520 | $146 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 36 | $9,955 | None |
| New patient visit (30+ min) | 104 | $9,468 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,453 | $175 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 68 | $466 | None |
Drugs they prescribed that Part D paid
$6,323
Pharmacies billed $6,323 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (73 of 236) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
230 generic and fewer than 11 brand-name prescriptions · $6,323 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 44 | $3,102 | $38 |
| Hydrocodone-Acetaminophen | 46 | $549 | $11 |
| Oxycodone-Acetaminophen | 13 | $188 | $12 |
| Meloxicam | 18 | $108 | $3 |
Year by year
| 2024 | 236 | 121 | 31% (73) | None | $6,323 |
| 2023 | 329 | 140 | 40% (130) | None | $11,200 |
| 2022 | 296 | 135 | 41% (120) | None | $16,657 |
| 2021 | 352 | 167 | 38% (132) | None | $18,189 |
| 2020 | 345 | 160 | 27% (94) | None | $17,953 |
| 2019 | 408 | 190 | 20% (80) | 13% | $14,998 |
| 2018 | 341 | 161 | 18% (61) | 23% | $14,164 |
| 2017 | 412 | 193 | 20% (84) | 22% | $16,524 |
| 2016 | 375 | 194 | 27% (100) | 15% | $15,021 |
| 2015 | 326 | 149 | 37% (121) | 24% | $9,966 |
| 2014 | 323 | 137 | 31% (101) | 21% | $9,630 |
| 2013 | 327 | 129 | 32% (103) | 11% | $10,620 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Celecoxib | 83 | $4,878 | $59 |
| Hydrocodone-Acetaminophen | 83 | $928 | $11 |
| Oxycodone-Acetaminophen | 25 | $255 | $10 |
| Meloxicam | 52 | $222 | $4 |
| Ondansetron | 11 | $144 | $13 |
| Tramadol | 17 | $67 | $4 |
| Amoxicillin | 13 | $29 | $2 |
2022: 5 drugs
| Celecoxib | 91 | $5,544 | $61 |
| Hydrocodone-Acetaminophen | 94 | $865 | $9 |
| Gabapentin | 16 | $211 | $13 |
| Oxycodone-Acetaminophen | 13 | $148 | $11 |
| Meloxicam | 21 | $94 | $4 |
2021: 7 drugs
| Celecoxib | 64 | $3,536 | $55 |
| Diclofenac | 64 | $1,380 | $22 |
| Hydrocodone-Acetaminophen | 99 | $1,045 | $11 |
| Gabapentin | 23 | $313 | $14 |
| Oxycodone-Acetaminophen | 14 | $194 | $14 |
| Meloxicam | 23 | $111 | $5 |
| Tramadol | 14 | $48 | $3 |
2020: 6 drugs
| Celecoxib | 53 | $3,349 | $63 |
| Diclofenac | 103 | $2,837 | $28 |
| Hydrocodone-Acetaminophen | 66 | $695 | $11 |
| Oxycodone-Acetaminophen | 18 | $355 | $20 |
| Meloxicam | 26 | $137 | $5 |
| Amoxicillin | 18 | $59 | $3 |
2019: 7 drugs
| Diclofenac | 137 | $4,297 | $31 |
| Voltaren | 42 | $4,172 | $99 |
| Celecoxib | 72 | $3,578 | $50 |
| Hydrocodone-Acetaminophen | 55 | $697 | $13 |
| Meloxicam | 36 | $199 | $6 |
| Amoxicillin | 12 | $44 | $4 |
| Tramadol | 13 | $41 | $3 |
2018: 8 drugs
| Celecoxib | 46 | $5,917 | $129 |
| Diclofenac | 84 | $3,108 | $37 |
| Voltaren | 52 | $3,067 | $59 |
| Oxycodone-Acetaminophen | 19 | $408 | $21 |
| Hydrocodone-Acetaminophen | 19 | $265 | $14 |
| Meloxicam | 32 | $185 | $6 |
| Tramadol | 21 | $157 | $7 |
| Amoxicillin | 17 | $53 | $3 |
2017: 9 drugs
| Voltaren | 61 | $3,376 | $55 |
| Celecoxib | 30 | $3,239 | $108 |
| Diclofenac | 44 | $1,442 | $33 |
| Hydrocodone-Acetaminophen | 47 | $579 | $12 |
| Tamsulosin | 23 | $473 | $21 |
| Oxycodone-Acetaminophen | 18 | $315 | $18 |
| Meloxicam | 53 | $211 | $4 |
| Gabapentin | 12 | $134 | $11 |
| Amoxicillin | 24 | $77 | $3 |
2016: 10 drugs
| Celecoxib | 40 | $2,588 | $65 |
| Voltaren | 35 | $1,835 | $52 |
| Hydrocodone-Acetaminophen | 53 | $1,008 | $19 |
| Oxycodone-Acetaminophen | 25 | $956 | $38 |
| Diclofenac | 13 | $353 | $27 |
| Meloxicam | 54 | $272 | $5 |
| Gabapentin | 17 | $217 | $13 |
| Naproxen | 11 | $215 | $20 |
| Amoxicillin | 20 | $85 | $4 |
| Tramadol | 12 | $76 | $6 |
2015: 7 drugs
| Voltaren | 58 | $3,051 | $53 |
| Celecoxib | 26 | $2,277 | $88 |
| Oxycodone-Acetaminophen | 34 | $1,744 | $51 |
| Hydrocodone-Acetaminophen | 62 | $1,253 | $20 |
| Gabapentin | 30 | $411 | $14 |
| Meloxicam | 29 | $104 | $4 |
| Tramadol | 12 | $56 | $5 |
2014: 7 drugs
| Celebrex | 15 | $3,144 | $210 |
| Voltaren | 41 | $1,780 | $43 |
| Hydrocodone-Acetaminophen | 79 | $1,074 | $14 |
| Meloxicam | 77 | $411 | $5 |
| Oxycodone-Acetaminophen | 11 | $361 | $33 |
| Gabapentin | 13 | $196 | $15 |
| Amoxicillin | 16 | $70 | $4 |
2013: 6 drugs
| Hydrocodone-Acetaminophen | 73 | $818 | $11 |
| Piroxicam | 13 | $695 | $53 |
| Voltaren | 17 | $655 | $39 |
| Meloxicam | 78 | $556 | $7 |
| Gabapentin | 25 | $258 | $10 |
| Naproxen | 14 | $118 | $8 |
Money from drug and device companies
$41 in 2025
| 2025 | 1 | 2 | None | $41 |
| 2023 | 1 | 1 | None | $18 |
| 2022 | 2 | 2 | None | $36 |
| 2021 | 4 | 6 | None | $440 |
| 2019 | 3 | 6 | None | $279 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aquamantys(Tm) | $41 | 2 payments
|
See all 2 published payments
| Medtronic | Meals · 2025-11-05 | Aquamantys(Tm) | $22 |
| Medtronic | Meals · 2025-09-09 | Aquamantys(Tm) | $19 |
See earlier years (2023, 2022, 2021, 2019)
2023: $18
| Stryker | Aequalis Flex Revive | $18 | 1 payment
|
2022: $36
| Janssen Biotech | None | $21 | 1 payment
|
| Heraeus Medical | Palacos | $15 | 1 payment
|
2021: $440
| DePuy Synthes Sales | Velys | $321 | 1 payment
|
| Janssen Biotech | None | $59 | 3 payments
|
| Heraeus Medical | Palacos | $34 | 1 payment
|
| 180 Medical | None | $25 | 1 payment
|
2019: $279
| DePuy Synthes Sales | Lcp Plates & Screws | $166 | 2 payments
|
| Stryker | A3 | $100 | 3 payments
|
| Horizon Therapeutics plc | Pennsaid | $13 | 1 payment
|
Professional record
- NPI
- 1457675209
- Licence
- CA A103526California A103526: Current · expires 2027-11-30
- Trained
- University of California, San Francisco School of Medicine, 2006
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2010-03-23
- NPI last updated
- 2012-09-14
This is when the NPI record was last certified, not a medical board exam.